Therapeutic potential of mesenchymal stem cells in regenerative medicine
DM Patel, J Shah, AS Srivastava - Stem cells international, 2013 - Wiley Online Library
Mesenchymal stem cells (MSCs) are stromal cells that have the ability to self‐renew and
also exhibit multilineage differentiation into both mesenchymal and nonmesenchymal …
also exhibit multilineage differentiation into both mesenchymal and nonmesenchymal …
Recent advances on drug-loaded mesenchymal stem cells with anti-neoplastic agents for targeted treatment of cancer
Mesenchymal stem cells (MSCs), as an undifferentiated group of adult multipotent cells,
have remarkable antitumor features that bring them up as a novel choice to treat cancers …
have remarkable antitumor features that bring them up as a novel choice to treat cancers …
Stem cell therapies in kidney diseases: progress and challenges
C Rota, M Morigi, B Imberti - International journal of molecular sciences, 2019 - mdpi.com
The prevalence of renal diseases is emerging as a public health problem. Despite major
progress in supportive therapy, mortality rates among patients remain high. In an attempt to …
progress in supportive therapy, mortality rates among patients remain high. In an attempt to …
Cell-based therapies for experimental chronic kidney disease: a systematic review and meta-analysis
DA Papazova, NR Oosterhuis… - Disease models & …, 2015 - journals.biologists.com
Cell-based therapy is a promising strategy for treating chronic kidney disease (CKD) and is
currently the focus of preclinical studies. We performed a systematic review and meta …
currently the focus of preclinical studies. We performed a systematic review and meta …
Mesenchymal stem cells—potential applications in kidney diseases
B Bochon, M Kozubska, G Surygała… - International journal of …, 2019 - mdpi.com
Mesenchymal stem cells constitute a pool of cells present throughout the lifetime in
numerous niches, characteristic of unlimited replication potential and the ability to …
numerous niches, characteristic of unlimited replication potential and the ability to …
Beneficial effects of systemically administered human muse cells in adriamycin nephropathy
N Uchida, Y Kushida, M Kitada, S Wakao… - Journal of the …, 2017 - journals.lww.com
Multilineage-differentiating stress-enduring (Muse) cells are nontumorigenic endogenous
pluripotent-like stem cells that can be collected from various organs. Intravenously …
pluripotent-like stem cells that can be collected from various organs. Intravenously …
Microparticles from kidney-derived mesenchymal stem cells act as carriers of proangiogenic signals and contribute to recovery from acute kidney injury
HY Choi, SJ Moon, BB Ratliff, SH Ahn, A Jung, M Lee… - PloS one, 2014 - journals.plos.org
We recently demonstrated the use of in vitro expanded kidney-derived mesenchymal stem
cells (KMSC) protected peritubular capillary endothelial cells in acute renal ischemia …
cells (KMSC) protected peritubular capillary endothelial cells in acute renal ischemia …
Mesenchymal stem cell derived extracellular vesicles ameliorate kidney injury in aristolochic acid nephropathy
S Kholia, MB Herrera Sanchez, M Cedrino… - Frontiers in cell and …, 2020 - frontiersin.org
Limitations in the current therapeutic strategies for the prevention of progression of chronic
kidney disease (CKD) to end stage renal disease has been a drawback to improving patient …
kidney disease (CKD) to end stage renal disease has been a drawback to improving patient …
Concise reviews: stem cells and kidney regeneration: an update
J Marcheque, B Bussolati, M Csete… - Stem cells translational …, 2019 - academic.oup.com
Significant progress has been made to advance stem cell products as potential therapies for
kidney diseases: various kinds of stem cells can restore renal function in preclinical models …
kidney diseases: various kinds of stem cells can restore renal function in preclinical models …